Barclays’s Traws Pharma TRAW Stock Holding History

Barclays’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-173	Closed	-$65K	–	5113
2021 Q1	$65K	Buy	173 +170	+5,667%	+$64.1K	﹤0.01%	4144
2020 Q4	$0	Hold	3	–	–	﹤0.01%	5190
2020 Q3	$0	Sell	3 -264	-99%	-$65.3K	﹤0.01%	5648
2020 Q2	$57K	Buy	+267	New	+$40.8K	﹤0.01%	4868
2020 Q1	–	Hold	0	–	–	–	6519
2019 Q4	–	Hold	0	–	–	–	6881
2019 Q3	–	Hold	0	–	–	–	7192
2018 Q2	–	Hold	0	–	–	–	7342
2018 Q1	–	Hold	0	–	–	–	7381
2015 Q2	–	Hold	0	–	–	–	7238
2015 Q1	–	Hold	0	–	–	–	7296
2014 Q4	–	Hold	0	–	–	–	7130
2014 Q3	–	Hold	0	–	–	–	7129
2014 Q2	–	Hold	0	–	–	–	6379
2014 Q1	–	Hold	0	–	–	–	6538
2013 Q4	–	Hold	0	–	–	–	7457
2013 Q3	–	Hold	0	–	–	–	6829

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Barclays's TRAW Position: Q2 2021 in Review

Barclays sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 173 shares — an estimated $65K sold.

Barclays first reported a position in TRAW in Q2 2020 and held it in 4 quarters. The position peaked at $65K in Q1 2021. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

Barclays reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
Barclays sold 173 Traws Pharma shares in Q2 2021, an estimated $65K.
Barclays first reported a position in Traws Pharma in Q2 2020 and held it in 4 quarters.
Barclays's Traws Pharma position peaked at $65K in Q1 2021.
25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.